BEAM
Price
$26.45
Change
-$2.13 (-7.45%)
Updated
Dec 18, 04:59 PM (EDT)
76 days until earnings call
CDXS
Price
$5.19
Change
-$0.44 (-7.82%)
Updated
Dec 18, 04:59 PM (EDT)
70 days until earnings call
Ad is loading...

BEAM vs CDXS

Header iconBEAM vs CDXS Comparison
Open Charts BEAM vs CDXSBanner chart's image
Beam Therapeutics
Price$26.45
Change-$2.13 (-7.45%)
Volume$26.28K
CapitalizationN/A
Codexis
Price$5.19
Change-$0.44 (-7.82%)
Volume$17.92K
CapitalizationN/A
BEAM vs CDXS Comparison Chart
Loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CDXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BEAM vs. CDXS commentary
Dec 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a Hold and CDXS is a Buy.

COMPARISON
Comparison
Dec 18, 2024
Stock price -- (BEAM: $28.58 vs. CDXS: $5.63)
Brand notoriety: BEAM and CDXS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 130% vs. CDXS: 132%
Market capitalization -- BEAM: $2.4B vs. CDXS: $456.53M
BEAM [@Biotechnology] is valued at $2.4B. CDXS’s [@Biotechnology] market capitalization is $456.53M. The market cap for tickers in the [@Biotechnology] industry ranges from $486.73B to $0. The average market capitalization across the [@Biotechnology] industry is $2.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 0 FA rating(s) are green whileCDXS’s FA Score has 0 green FA rating(s).

  • BEAM’s FA Score: 0 green, 5 red.
  • CDXS’s FA Score: 0 green, 5 red.
According to our system of comparison, BEAM is a better buy in the long-term than CDXS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 5 TA indicator(s) are bullish while CDXS’s TA Score has 3 bullish TA indicator(s).

  • BEAM’s TA Score: 5 bullish, 4 bearish.
  • CDXS’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, BEAM is a better buy in the short-term than CDXS.

Price Growth

BEAM (@Biotechnology) experienced а -5.36% price change this week, while CDXS (@Biotechnology) price change was -0.71% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.67%. For the same industry, the average monthly price growth was -1.92%, and the average quarterly price growth was +0.65%.

Reported Earning Dates

BEAM is expected to report earnings on Mar 04, 2025.

CDXS is expected to report earnings on Feb 26, 2025.

Industries' Descriptions

@Biotechnology (-6.67% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BEAM($2.4B) has a higher market cap than CDXS($457M). CDXS YTD gains are higher at: 84.590 vs. BEAM (4.996). CDXS has higher annual earnings (EBITDA): -30.09M vs. BEAM (-160.83M). BEAM has more cash in the bank: 926M vs. CDXS (90.3M). CDXS has less debt than BEAM: CDXS (41.8M) vs BEAM (162M). BEAM has higher revenues than CDXS: BEAM (350M) vs CDXS (64.4M).
BEAMCDXSBEAM / CDXS
Capitalization2.4B457M524%
EBITDA-160.83M-30.09M534%
Gain YTD4.99684.5906%
P/E RatioN/AN/A-
Revenue350M64.4M543%
Total Cash926M90.3M1,025%
Total Debt162M41.8M388%
FUNDAMENTALS RATINGS
CDXS: Fundamental Ratings
CDXS
OUTLOOK RATING
1..100
29
VALUATION
overvalued / fair valued / undervalued
1..100
58
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
35
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BEAMCDXS
RSI
ODDS (%)
Bearish Trend 6 days ago
85%
Bearish Trend 2 days ago
89%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
80%
N/A
MACD
ODDS (%)
Bullish Trend 2 days ago
82%
N/A
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
82%
Advances
ODDS (%)
Bullish Trend 9 days ago
81%
Bullish Trend 2 days ago
84%
Declines
ODDS (%)
Bearish Trend 6 days ago
85%
Bearish Trend 6 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
84%
View a ticker or compare two or three
Ad is loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CDXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GSISX28.78N/A
N/A
Goldman Sachs International Eq ESG Svc
VBIAX51.17-0.16
-0.31%
Vanguard Balanced Index Adm
JDIAX46.26-0.20
-0.43%
Janus Henderson Overseas A
HUSIX28.74-0.37
-1.27%
Huber Small Cap Value Inv
LMISX25.10-0.97
-3.70%
Franklin U.S. Large Cap Equity IS